NCT01791946

Brief Summary

The primary objective of this study is to assess the effectiveness of an investigational binocular treatment in improving vision in strabismic amblyopes (i.e., patients with lazy eye, or poor vision in one eye due to a present or former eye misalignment). Patients will be randomized to receive the study treatment either before or after strabismus surgery (i.e., corrective eye alignment surgery) or sham treatment before surgery. The study hypothesis is that there will be no significant change in vision in neither the pre nor post-surgery groups and no significant change in vision in neither the sham nor actual treatment groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 7, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 15, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

January 13, 2017

Status Verified

October 1, 2015

Enrollment Period

3.7 years

First QC Date

February 7, 2013

Last Update Submit

January 12, 2017

Conditions

Keywords

lazy eyecross eyecross eyed

Outcome Measures

Primary Outcomes (1)

  • The primary outcome variable is a composite of the difference in visual acuity and stereo vision measurements taken before binocular treatment and strabismus surgery versus after binocular treatment and strabismus surgery.

    This is a change outcome measure. That is measurements will be taken at baseline, 6 weeks, and approximately 3 months.

Study Arms (3)

Treatment Group A (Post-Surgery)

EXPERIMENTAL

Subjects enrolled in this arm will first have eye alignment corrective surgery and then complete six weeks of the investigational binocular treatment training.

Procedure: Binocular Treatment

Treatment Group B (Pre-Surgery)

EXPERIMENTAL

Subjects enrolled in this arm will first complete six weeks of the investigational binocular treatment training and then have eye alignment corrective surgery.

Procedure: Binocular Treatment

Sham Treatment

SHAM COMPARATOR

Subjects enrolled in this arm will first complete six weeks of the sham binocular treatment and then undergo eye alignment corrective surgery.

Procedure: Sham Binocular Treatment

Interventions

The binocular treatment involves the completion of visual tasks via virtual reality goggles. The stimulus is presented to each eye separately, allowing for varying levels of contrast to be presented to each eye. (The visual task is therefore made more or less difficult with the variation of contrast presented to either eye.) Subjects will complete the computer-based visual tasks for approximately 36 hours total over the course of six weeks, or six hours per week for six weeks.

Treatment Group A (Post-Surgery)Treatment Group B (Pre-Surgery)

The sham treatment involves the same computer-based visual tasks and timeframe as the binocular treatment training but there will be no variation in contrast presentation to either eye.

Sham Treatment

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Presence of amblyopia in one eye due to congenital strabismus.
  • Amblyopic eye has a fully-corrected visual acuity of 20/30 or less with no other cause for the visual loss except amblyopia.
  • Patient is 18 to 60 years old.
  • Corrected vision in other eye is normal.
  • Eligible for strabismus surgery or has completed it previously with a successful outcome, as determined by the treating physician.
  • Available and willing to comply with examination procedures and schedule.
  • Signed and dated informed consent.

You may not qualify if:

  • Fully-corrected visual acuity of less than 20/30 in both eyes.
  • Visual decrement due to anything other than amblyopia.
  • At high risk for developing intractable diplopia (double vision) if vision in weak eye is improved. (To be determined by treating physician.)
  • Unable or unavailable to complete at least 18 hours of binocular treatment over the course of six weeks.
  • Currently enrolled in another research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts Eye and Ear Infirmary

Boston, Massachusetts, 02114, United States

Location

Related Publications (2)

  • Hess RF, Mansouri B, Thompson B. Restoration of binocular vision in amblyopia. Strabismus. 2011 Sep;19(3):110-8. doi: 10.3109/09273972.2011.600418.

  • Hess RF, Mansouri B, Thompson B. A new binocular approach to the treatment of amblyopia in adults well beyond the critical period of visual development. Restor Neurol Neurosci. 2010;28(6):793-802. doi: 10.3233/RNN-2010-0550.

MeSH Terms

Conditions

AmblyopiaStrabismusEsotropia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve Diseases

Study Officials

  • Dean Cestari, M.D.

    Massachusetts Eye and Ear Infirmary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2013

First Posted

February 15, 2013

Study Start

January 1, 2013

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

January 13, 2017

Record last verified: 2015-10

Data Sharing

IPD Sharing
Will not share

We do not \[plan on sharing IPD with other researchers.

Locations